Clinical trial

Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

NCT02052128

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-01-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2014-01-01Date precision: month

Registry last updated2015-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapyunresolved

Interventions

onapristoneDRUG

Sponsors & collaborators

Arno Therapeuticslead sponsor

Mapped research locations

ParisFrance1 LilleFrance1 VillejuifFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02052128 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.